Financials
- Market Capitalization 8.53 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-9.03
Fiyat/satışlar oranı
52.32
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 990 | PCVX Vaxcyte, Inc. - Common Stock | 59.84 USD | -2.16% | -3.95% | +6.67% | +41.47% | 8.90 B USD | ||
| 992 | ABVX Abivax SA - American Depositary Shares | 113.35 USD | -0.83% | -0.57% | -10.93% | +41.67% | 8.90 B USD | ||
| 1014 | IMVT Immunovant, Inc. - Common Stock | 41.20 USD | -5.98% | -6.36% | +4.81% | +114.47% | 8.51 B USD | ||
| 1023 | APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD |